HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

solanezumab

in clinical trials (2010) for treatment of Alzheimer's disease
Also Known As:
LY 2062430; LY-2062430; LY2062430
Networked: 25 relevant articles (1 outcomes, 16 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Dean, Robert A: 5 articles (01/2013 - 03/2010)
2. Siemers, Eric: 4 articles (01/2015 - 07/2011)
3. Panza, Francesco: 4 articles (10/2014 - 02/2012)
4. Solfrizzi, Vincenzo: 4 articles (10/2014 - 02/2012)
5. Imbimbo, Bruno P: 4 articles (10/2014 - 02/2012)
6. Mohs, Richard: 3 articles (01/2015 - 07/2012)
7. Liu-Seifert, Hong: 3 articles (01/2015 - 01/2014)
8. Logroscino, Giancarlo: 3 articles (10/2014 - 03/2014)
9. Aisen, Paul S: 3 articles (04/2014 - 07/2012)
10. Farlow, Martin: 3 articles (04/2014 - 07/2012)

Related Diseases

1. Alzheimer Disease (Alzheimer's Disease)
2. Amyloid Plaque
3. Edema
4. Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
5. Meningoencephalitis

Related Drugs and Biologics

1. Amyloid (Amyloid Fibrils)
2. bapineuzumab
3. Monoclonal Antibodies
4. N2- ((2S)- 2- (3,5- difluorophenyl)- 2- hydroxyethanoyl)- N1- ((7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- L- alaninamide
5. Amyloid beta-Peptides
6. Antibodies
7. solanezumab
8. Peptides

Related Therapies and Procedures

1. Immunotherapy
2. Activities of Daily Living (ADL)